久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Novo Nordisk launches innovative insulin product in China

By Zhou Wenting | chinadaily.com.cn | Updated: 2019-12-07 16:21
Share
Share - WeChat
Novo Nordisk's products. [Photo provided to chinadaily.com.cn]

The world's first insulin product working for both a stable blood glucose level around the clock and a healthy postprandial blood glucose level was launched in the Chinese market in Shanghai on Saturday.

The innovative injection by Denmark's biopharmaceutical company Novo Nordisk that had been previously available in 29 countries and regions overseas after making its world market debut in 2012 was claimed to be "very suitable" for Chinese diabetes patients, who have a high need for controlling the postprandial blood glucose level as they take high-carbohydrate meals with a relatively high glycemic index.

Ji Linong, a leading medical expert in diabetes in China, said that it is probably so far the best insulin product that simulates the physiological secretion of insulin in the human body.

"Some current insulin injections may pose a threat to causing low blood glucose for patients, and such concerns may lead to some patients randomly reducing their amount of medicine use, which impairs the long-term control of blood glucose within a reasonable range," said Ji, who is also director of the endocrinology department at Peking University People's Hospital in Beijing.

Data from the International Diabetes Foundation showed that the incidence rate of the disease kept climbing up over the past three decades and reached 10.9 percent in China in 2017.

"Compared to their counterparts in Western countries, Chinese diabetes patients suffer more often from the abnormal rise of postprandial blood glucose, triggering fluctuation of blood glucose levels over 24 hours, which may often result in cardiovascular diseases, and can be fatal in serious cases," said Mu Yiming, director of the endocrinology department at the Beijing-based General Hospital of the Chinese People's Liberation Army.

The new insulin product, which requires only one injection a day, is composed of two types of insulin that can work independently from each other to respectively control blood glucose levels for 24 hours and longer and after meals, the company said.

At least 10 innovative drugs treating various chronic diseases are scheduled to be introduced to the Chinese market in the upcoming five years to better contribute to the Healthy China 2030 Initiative, the company said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 久久久网站亚洲第一 | 国产成人在线网址 | 日韩精品小视频 | 国产偷自拍| 一 级做人爱全视频在线看 一本不卡 | 国产午夜伦伦伦午夜伦 | 成人一级 | 成年免费a级毛片 | 日韩一级伦理片 | 就草草在线观看视频 | 国产成人一区二区三区视频免费 | 一级特一级特色生活片 | 黄色免费看片网站 | 国产亚洲高清在线精品不卡 | 国产亚洲男人的天堂在线观看 | 日韩一区二区三区不卡视频 | 国产一区二区三区在线观看视频 | 美国的毛片免费的 | 国产成人一区二区三区高清 | 曰韩一级 | 2021精品国产品免费观看 | 欧美视频一区二区三区精品 | 2018av男人天堂 | 国产成人啪精品视频免费网 | 日本亚欧乱色视频在线网站 | 成人久久网站 | 亚洲国产欧美在线成人aaaa | f性欧美 | 国产精品国产三级国产an | 国产精品揄拍一区二区 | 在线视频 自拍 | 一级做a爰片久久毛片欧美 一级做a爰片久久毛片人呢 | 国产精品视频男人的天堂 | 久久久久久久综合 | 午夜精品在线 | 国产精品成人免费视频 | 国产高清视频在线播放 | 成年女人毛片 | 久久爱噜噜噜噜久久久网 | 91久久精品国产一区二区 | 麻豆理论片 |